$1.15
0.010.88%
At close: -
$1.16
0.010.87%
After Hours: 5:11 PM EDT
Comments
Loading...
Marker Therapeutics (MRKR) Forecast
NewsEarningsMarker Therapeutics (MRKR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Marker Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MRKR | Benzinga
Explore Marker Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MRKR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Marker Therapeutics (MRKR) stock?
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Who are Marker Therapeutics (MRKR) competitors?
Other companies in Marker Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), Evaxion (NASDAQ:EVAX) and Can Fite Biofarma (AMEX:CANF).
What is the forecast, or price target, for Marker Therapeutics (MRKR) stock?
Marker Therapeutics has a consensus price target of $13.17.
What is the current price for Marker Therapeutics (MRKR)?
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.16 last updated May 27, 2025 at 5:11 PM EDT.
Does Marker Therapeutics (MRKR) pay a dividend?
There are no upcoming dividends for Marker Therapeutics.
When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?
Marker Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
Is Marker Therapeutics (MRKR) going to split?
There is no upcoming split for Marker Therapeutics.
What sector and industry does Marker Therapeutics (MRKR) operate in?
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
